Originally Posted by
KARFA
If that is deemed a complete course of doses in accordance with the product characteristics approved as part of the marketing authorisation by the EMA for an authorised vaccine, then the exemption applies.
If it isn't deemed as such, then frankly they have not been fully vaccinated regardless of what pass France is issuing to them, and they need to get the full course.
That may well be the case but it's quite harsh in the circumstances, given that a) individuals have to follow their own country's rules, b) that the scientific evidence shows that the French (and other countries' protocols on this are super-effective, and more so than a regular double dose, and c) that the UK doesn't follow the approved dosing regimen, by delaying the second dose for so long.
The situation highlights how all these rules which, understandably, have been hobbled together in a hurry and in a world where nobody is speaking to each other, will need to stabilise and evolve. And nobody yet is talking about expiration dates of the original vaccine doses and of the booster. If the WHO has any oomph left in it, it should start developing guidelines on these matters, to allow countries to reference the WHO's guidelines in there rules, and internally to operate within them.